I love helping my clients accomplish their missions and realize their potential.
About Kevin
Kevin Milgram's practice focuses on the formation and financing of emerging companies and M&A, as well as counseling companies regarding general corporate matters. He represents clients on a wide range of industries, including information technology, national security, unmanned aircraft, cyber security and software. His practice additionally focuses on veteran-owned startups. He also advises a number of leading venture capital and private equity firms.
Cooley advised Second Front Systems (2F), a public-benefit software company focused on enabling the delivery of mission-critical software solutions, on the close of its $70 million Series C funding round.
Propella Therapeutics Enters Merger Agreement With Astellas Pharma
November 16, 2023
Cooley advised Propella Therapeutics, a privately held biopharmaceutical company that has leveraged a wholly owned proprietary platform that combines medicinal chemistry with lymphatic targeting to create new oncology drugs, on its merger agreement with Astellas Pharma in which Astellas will acquire Propella through a US subsidiary.
